Skip to main content
. 2017 Nov 30;15(4):301–312. doi: 10.9758/cpn.2017.15.4.301

Table 1.

Summary of cannabinoids

Generic name Trade name Administration method Formulation Dosage Pharmacokinetics
Dronabinol Marinol Oral capsule Synthetic THC 2.5 mg, 5 mg, 10 mg tmax=2–4 hr. Completely absorbed (90–95%) after a single dose
Alpha (plasma) half-life: 4 hr
Beta (tissue) half-life: 25–36 hr*
Nabilone Cesamet Oral capsule Synthetic structural analogue of THC
Methylgroup at C9 and pentyl side chain in THC substituted with a ketone group and a dimethyl heptyl side chain respectively.
1 mg tmax=2 hr
Alpha (plasma) half-life: 2 hr
Beta (tissue) half-life: 35 hr*
Nabiximols Sativex Oromucosal spray Whole plant cannabis extract 2.7 mg THC and 2.5 mg CBD, per spray (100 μl) tmax=98–253 min
Variable plasma half-life of 85–130 min
Clearance within 12–24 hr after dose*
CBD None Oral capsule Cannabis plant extract Variable No available information in humans4)
THC Namisol Oral capsule Cannabis plant extract Variable tmax=1–2 hr
Half-life: 72–80 min5,6)

THC, tetrahydrocannabinol; CBD, cannabidiol.

*

Marinol (Abbott Products, 2010), Cesamet (Valeant Canada, 2009), and Sativex (GW Pharmaceutical, 2010).